| Date Filed | Type | Description |
| 08/17/2023 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on Xtant Medical Holdings, Inc.|
Txns:
| Granted 145,180 shares
@ $0
Granted 28,230 options to buy
@ $1.2, valued at
$33.9k
|
|
| 05/26/2023 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Sold 14,400 shares
@ $2.7, valued at
$38.9k
Granted 36,364 shares
@ $0 |
|
| 05/25/2023 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on TREACE MEDICAL CONCEPTS, INC.|
Txns:
| Granted 2,753 shares
@ $0
Granted 6,305 options to buy
@ $26.34, valued at
$166.1k
|
|
| 05/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2022 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on Xtant Medical Holdings, Inc.|
Txns:
| Granted 215,415 shares
@ $0 |
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on TREACE MEDICAL CONCEPTS, INC.|
Txns:
| Granted 2,295 shares
@ $0
Granted 16,625 options to buy
@ $15.8, valued at
$262.7k
|
|
| 02/11/2022 |
5
| BAKEWELL JOHN K (Director) has filed a Form 5 on TREACE MEDICAL CONCEPTS, INC. |
| 08/17/2021 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on Xtant Medical Holdings, Inc.|
Txns:
| Granted 85,337 shares
@ $0 |
|
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| BAKEWELL JOHN K (SVP, Research & Development) has filed a Form 4 on TREACE MEDICAL CONCEPTS, INC.|
Txns:
| Converted 342,300 shares
@ $0
Acquired 7,925 preferred shares
@ $0
Converted 342,300 preferred shares
@ $0 |
|
| 04/26/2021 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on TREACE MEDICAL CONCEPTS, INC.|
Txns:
| Granted 21,240 options to buy
@ $17, valued at
$361.1k
|
|
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/12/2020 |
3/A
| BAKEWELL JOHN K (Director) has filed a Form 3/A on Neuronetics, Inc. |
| 08/07/2020 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Granted 12,291 shares
@ $0 |
|
| 05/28/2020 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Granted 30,000 shares
@ $0 |
|
| 05/28/2020 |
3
| BAKEWELL JOHN K (Director) has filed a Form 3 on Neuronetics, Inc. |
| 02/07/2020 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on Xtant Medical Holdings, Inc.|
Txns:
| Granted 116,197 shares
@ $0 |
|
| 09/25/2019 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on Xtant Medical Holdings, Inc.|
Txns:
| Granted 5,555 shares
@ $0 |
|
| 04/10/2018 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on Xtant Medical Holdings, Inc.|
Txns:
| Granted 26,042 shares
@ $0 |
|
| 03/06/2018 |
4/A
| BAKEWELL JOHN K (Director) has filed a Form 4 on Corindus Vascular Robotics, Inc.|
Txns:
| Granted 32,072 shares
@ $0 |
|
| 03/01/2018 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on ENTELLUS MEDICAL INC|
Txns:
| Disposed/sold 2,500 shares
@ $24, valued at
$60k
Disposed/sold 10,000 options to buy
@ $18.26, valued at
$182.6k
Disposed/sold 5,000 options to buy
@ $13.38, valued at
$66.9k
|
|
| 02/23/2018 |
3
| BAKEWELL JOHN K (Director) has filed a Form 3 on Xtant Medical Holdings, Inc. |
| 12/19/2017 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on Corindus Vascular Robotics, Inc.|
Txns:
| Granted 32,072 restricted stock units
@ $0 |
|
| 08/08/2017 |
3
| BAKEWELL JOHN K (Director) has filed a Form 3 on Corindus Vascular Robotics, Inc. |
| 06/14/2017 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on ENTELLUS MEDICAL INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 5,000 options to buy
@ $13.38, valued at
$66.9k
|
|
| 06/15/2016 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on ENTELLUS MEDICAL INC |
| 01/05/2016 |
4
| BAKEWELL JOHN K (CFO) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Granted 238,095 restricted stock units
@ $0
Granted 14,175 restricted stock units
@ $0 |
|
| 01/04/2016 |
4
| BAKEWELL JOHN K (CFO and Treasurer) has filed a Form 4 on Lantheus Holdings, Inc.|
Txns:
| Disposed/sold 83,500 shares
@ $0 |
|
| 10/02/2015 |
4
| BAKEWELL JOHN K (CFO and Treasurer) has filed a Form 4 on Lantheus Holdings, Inc.|
Txns:
| Granted 25,000 shares
@ $0 |
|
| 09/03/2015 |
4
| BAKEWELL JOHN K (CFO and Treasurer) has filed a Form 4 on Lantheus Holdings, Inc.|
Txns:
| Granted 58,500 shares
@ $0 |
|
| 07/09/2015 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on ENTELLUS MEDICAL INC|
Txns:
| Granted 15,000 options to buy
@ $24.6, valued at
$369k
|
|
| 07/13/2010 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on ev3 Inc.|
Txns:
| Unknown transaction of 11,723 shares
@ $22.5, valued at
$263.8k
Disposed/sold 4,148 shares
@ $22.5, valued at
$93.3k
Disposed/sold 5,833 options to buy
@ $17.71, valued at
$103.3k
Disposed/sold 13,334 options to buy
@ $13.84, valued at
$184.5k
Disposed/sold 19,841 options to buy
@ $9.04, valued at
$179.4k
Disposed/sold 20,000 options to buy
@ $16.66, valued at
$333.2k
Disposed/sold 20,696 options to buy
@ $9.9, valued at
$204.9k
Disposed/sold 10,833 options to buy
@ $17.71, valued at
$191.9k
|
|
| 12/11/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|